世界の痔核治療の市場規模は、2024年に7億6,299万米ドルと推定され、、2025年から2033年にかけて7.5%のCAGRで成長し、2033年までに14億6,528万米ドルに達すると予想されます。痔核疾患の有病率の増加が、座りがちなライフスタイル、偏った食生活、肥満の増加、組織の弾力性を低下させる加齢の影響を受けて、市場の成長を推進しています。
目次
Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Disease
1.2.2. Drug Class
1.2.3. Distribution Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. GVR’s Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Hemorrhoids Treatment Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Market Dynamics
3.2.1. Market Driver Analysis
3.2.2. Market Restraint Analysis
3.3. Business Environment Analysis
3.3.1. Industry Analysis - Porter’s Five Forces Analysis
3.3.1.1. Supplier Power
3.3.1.2. Buyer Power
3.3.1.3. Substitution Threat
3.3.1.4. Threat of New Entrants
3.3.1.5. Competitive Rivalry
3.3.2. PESTLE Analysis
3.3.3. Pipeline Analysis
3.3.4. Pricing Analysis
Chapter 4. Hemorrhoids Treatment Market: Disease Business Analysis
4.1. Disease Market Share, 2024 & 2033
4.2. Disease Segment Dashboard
4.3. Market Size & Forecasts and Trend Analysis, by Disease, 2021 to 2033 (USD Million)
4.4. Internal Hemorrhoids
4.4.1. Internal Hemorrhoids Market, 2021 - 2033 (USD Million)
4.5. External Hemorrhoids
4.5.1. External Hemorrhoids Market, 2021 - 2033 (USD Million)
4.6. Mixed Hemorrhoids
4.6.1. Mixed Hemorrhoids Market, 2021 - 2033 (USD Million)
Chapter 5. Hemorrhoids Treatment Market: Drug Class Business Analysis
5.1. Drug Class Market Share, 2024 & 2033
5.2. Drug Class Segment Dashboard
5.3. Market Size & Forecasts and Trend Analysis, by Drug Class, 2021 to 2033 (USD Million)
5.4. Corticosteroids
5.4.1. Corticosteroids Market, 2021 - 2033 (USD Million)
5.5. Local Anesthetics
5.5.1. Local Anesthetics Market, 2021 - 2033 (USD Million)
5.6. Vasoconstrictors
5.6.1. Vasoconstrictors Market, 2021 - 2033 (USD Million)
5.7. Others
5.7.1. Others Market, 2021 - 2033 (USD Million)
Chapter 6. Hemorrhoids Treatment Market: Distribution Channel Business Analysis
6.1. Distribution Channel Market Share, 2024 & 2033
6.2. Distribution Channel Segment Dashboard
6.3. Market Size & Forecasts and Trend Analysis, by Distribution Channel, 2021 to 2033 (USD Million)
6.4. Online Pharmacy
6.4.1. Online Pharmacy Market, 2021 - 2033 (USD Million)
6.5. Retail Pharmacy
6.5.1. Retail Pharmacy Market, 2021 - 2033 (USD Million)
6.6. Hospital Pharmacy
6.6.1. Hospital Pharmacy Market, 2021 - 2033 (USD Million)
Chapter 7. Hemorrhoids Treatment Market: Regional Estimates & Trend Analysis
7.1. Regional Market Share Analysis, 2024 & 2033
7.2. Regional Market Dashboard
7.3. Market Size & Forecasts Trend Analysis, 2021 to 2033:
7.4. North America
7.4.1. North America Hemorrhoids Treatment Market Estimates and Forecasts, By Country, 2021 - 2033 (USD Million)
7.4.2. U.S.
7.4.2.1. Key Country Dynamics
7.4.2.2. Target Disease Prevalence
7.4.2.3. Regulatory Framework
7.4.2.4. Reimbursement Framework
7.4.2.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.3. Canada
7.4.3.1. Key Country Dynamics
7.4.3.2. Target Disease Prevalence
7.4.3.3. Regulatory Framework
7.4.3.4. Reimbursement Framework
7.4.3.5. U.S. Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.4.4. Mexico
7.4.4.1. Key Country Dynamics
7.4.4.2. Target Disease Prevalence
7.4.4.3. Regulatory Framework
7.4.4.4. Reimbursement Framework
7.4.4.5. Mexico Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5. Europe
7.5.1. Europe Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.2. UK
7.5.2.1. Key Country Dynamics
7.5.2.2. Target Disease Prevalence
7.5.2.3. Regulatory Framework
7.5.2.4. Reimbursement Framework
7.5.2.5. Uk Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.3. Germany
7.5.3.1. Key Country Dynamics
7.5.3.2. Target Disease Prevalence
7.5.3.3. Regulatory Framework
7.5.3.4. Reimbursement Framework
7.5.3.5. Germany Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.4. France
7.5.4.1. Key Country Dynamics
7.5.4.2. Target Disease Prevalence
7.5.4.3. Regulatory Framework
7.5.4.4. Reimbursement Framework
7.5.4.5. France Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.5. Italy
7.5.5.1. Key Country Dynamics
7.5.5.2. Target Disease Prevalence
7.5.5.3. Regulatory Framework
7.5.5.4. Reimbursement Framework
7.5.5.5. Italy Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.6. Spain
7.5.6.1. Key Country Dynamics
7.5.6.2. Target Disease Prevalence
7.5.6.3. Regulatory Framework
7.5.6.4. Reimbursement Framework
7.5.6.5. Spain Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.7. Denmark
7.5.7.1. Key Country Dynamics
7.5.7.2. Target Disease Prevalence
7.5.7.3. Regulatory Framework
7.5.7.4. Reimbursement Framework
7.5.7.5. Denmark Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.8. Sweden
7.5.8.1. Key Country Dynamics
7.5.8.2. Target Disease Prevalence
7.5.8.3. Regulatory Framework
7.5.8.4. Reimbursement Framework
7.5.8.5. Sweden Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.5.9. Norway
7.5.9.1. Key Country Dynamics
7.5.9.2. Target Disease Prevalence
7.5.9.3. Regulatory Framework
7.5.9.4. Reimbursement Framework
7.5.9.5. Norway Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6. Asia Pacific
7.6.1. Asia Pacific Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.2. Japan
7.6.2.1. Key Country Dynamics
7.6.2.2. Target Disease Prevalence
7.6.2.3. Regulatory Framework
7.6.2.4. Reimbursement Framework
7.6.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.3. China
7.6.3.1. Key Country Dynamics
7.6.3.2. Target Disease Prevalence
7.6.3.3. Regulatory Framework
7.6.3.4. Reimbursement Framework
7.6.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.4. India
7.6.4.1. Key Country Dynamics
7.6.4.2. Target Disease Prevalence
7.6.4.3. Regulatory Framework
7.6.4.4. Reimbursement Framework
7.6.4.5. India Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.5. Australia
7.6.5.1. Key Country Dynamics
7.6.5.2. Target Disease Prevalence
7.6.5.3. Regulatory Framework
7.6.5.4. Reimbursement Framework
7.6.5.5. Australia Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.6. South Korea
7.6.6.1. Key Country Dynamics
7.6.6.2. Target Disease Prevalence
7.6.6.3. Regulatory Framework
7.6.6.4. Reimbursement Framework
7.6.6.5. South Korea Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.6.7. Thailand
7.6.7.1. Key Country Dynamics
7.6.7.2. Target Disease Prevalence
7.6.7.3. Regulatory Framework
7.6.7.4. Reimbursement Framework
7.6.7.5. Thailand Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7. Latin America
7.7.1. Latin America Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.2. Brazil
7.7.2.1. Key Country Dynamics
7.7.2.2. Target Disease Prevalence
7.7.2.3. Regulatory Framework
7.7.2.4. Reimbursement Framework
7.7.2.5. Japan Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.7.3. Argentina
7.7.3.1. Key Country Dynamics
7.7.3.2. Target Disease Prevalence
7.7.3.3. Regulatory Framework
7.7.3.4. Reimbursement Framework
7.7.3.5. China Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8. Middle East and Africa
7.8.1. Middle East and Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.2. South Africa
7.8.2.1. Key Country Dynamics
7.8.2.2. Target Disease Prevalence
7.8.2.3. Regulatory Framework
7.8.2.4. Reimbursement Framework
7.8.2.5. South Africa Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.3. Saudi Arabia
7.8.3.1. Key Country Dynamics
7.8.3.2. Target Disease Prevalence
7.8.3.3. Regulatory Framework
7.8.3.4. Reimbursement Framework
7.8.3.5. Saudi Arabia Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.4. UAE
7.8.4.1. Key Country Dynamics
7.8.4.2. Target Disease Prevalence
7.8.4.3. Regulatory Framework
7.8.4.4. Reimbursement Framework
7.8.4.5. UAE Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
7.8.5. Kuwait
7.8.5.1. Key Country Dynamics
7.8.5.2. Target Disease Prevalence
7.8.5.3. Regulatory Framework
7.8.5.4. Reimbursement Framework
7.8.5.5. Kuwait Hemorrhoids Treatment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
Chapter 8. Competitive Landscape
8.1. Participant Overview
8.2. Company Market Position Analysis
8.3. Company Categorization
8.4. Strategy Mapping
8.5. Company Profiles/Listing
8.5.1. Lupin
8.5.1.1. Overview
8.5.1.2. Financial Performance
8.5.1.3. Product Benchmarking
8.5.1.4. Strategic Initiatives
8.5.2. Cipla
8.5.2.1. Overview
8.5.2.2. Financial Performance
8.5.2.3. Product Benchmarking
8.5.2.4. Strategic Initiatives
8.5.3. Amato Pharmaceutical Products, Ltd.
8.5.3.1. Overview
8.5.3.2. Financial Performance
8.5.3.3. Product Benchmarking
8.5.3.4. Strategic Initiatives
8.5.4. Church & Dwight Co., Inc
8.5.4.1. Overview
8.5.4.2. Financial Performance
8.5.4.3. Product Benchmarking
8.5.4.4. Strategic Initiatives
8.5.5. Haleon Group of Companies
8.5.5.1. Overview
8.5.5.2. Financial Performance
8.5.5.3. Product Benchmarking
8.5.5.4. Strategic Initiatives
8.5.6. Sebela Pharmaceuticals
8.5.6.1. Overview
8.5.6.2. Financial Performance
8.5.6.3. Product Benchmarking
8.5.6.4. Strategic Initiatives
8.5.7. Bayer AG
8.5.7.1. Overview
8.5.7.2. Financial Performance
8.5.7.3. Product Benchmarking
8.5.7.4. Strategic Initiatives
8.5.8. Sanofi
8.5.8.1. Overview
8.5.8.2. Financial Performance
8.5.8.3. Product Benchmarking
8.5.8.4. Strategic Initiatives
8.5.9. Abbott
8.5.9.1. Overview
8.5.9.2. Financial Performance
8.5.9.3. Product Benchmarking
8.5.9.4. Strategic Initiatives
8.5.10. Sun Pharmaceutical Industries, Inc
8.5.10.1. Overview
8.5.10.2. Financial Performance
8.5.10.3. Product Benchmarking
8.5.10.4. Strategic Initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. Global hemorrhoids treatment market, by region, 2021 - 2033 (USD Million)
Table 4. Global hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 5. Global hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 6. Global hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 7. North America hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
Table 8. North America hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 9. North America hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 10. North America hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 11. U.S. hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 12. U.S. hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 13. U.S. hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 14. Canada hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 15. Canada hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 16. Canada hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 17. Mexico hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 18. Mexico hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 19. Mexico hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 20. Europe hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
Table 21. Europe hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 22. Europe hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 23. Europe hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 24. UK hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 25. UK hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 26. UK hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 27. Germany hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 28. Germany hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 29. Germany hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 30. France hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 31. France hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 32. France hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 33. Italy hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 34. Italy hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 35. Italy hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 36. Spain hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 37. Spain hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 38. Spain hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 39. Norway hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 40. Norway hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 41. Norway hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 42. Denmark hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 43. Denmark hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 44. Denmark hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 45. Sweden hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 46. Sweden hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 47. Sweden hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 48. Asia Pacific hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
Table 49. Asia Pacific hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 50. Asia Pacific hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 51. Asia Pacific hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD
Table 52. Japan hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 53. Japan hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 54. Japan hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 55. China hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 56. China hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 57. China hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 58. India hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 59. India hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 60. India hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 61. Australia hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 62. Australia hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 63. Australia hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 64. South Korea hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 65. South Korea hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 66. South Korea hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 67. Thailand hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 68. Thailand hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 69. Thailand hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 70. Latin America hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
Table 71. Latin America hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 72. Latin America hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 73. Latin America hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 74. Brazil hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 75. Brazil hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 76. Brazil hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 77. Argentina hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 78. Argentina hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 79. Argentina hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 80. Middle East & Africa Hemorrhoids treatment market, by country, 2021 - 2033 (USD Million)
Table 81. Middle East & Africa hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 82. Middle East & Africa hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 83. Middle East & Africa hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 84. South Africa hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 85. South Africa hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 86. South Africa hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 87. Saudi Arabia hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 88. Saudi Arabia hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 89. Saudi Arabia hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 90. UAE hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 91. UAE hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 92. UAE hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
Table 93. Kuwait hemorrhoids treatment market, by disease, 2021 - 2033 (USD Million)
Table 94. Kuwait hemorrhoids treatment market, by drug class, 2021 - 2033 (USD Million)
Table 95. Kuwait hemorrhoids treatment market, by distribution channel, 2021 - 2033 (USD Million)
List of Figures
Fig. 1 Hemorrhoids treatment market segmentation
Fig. 2 Market research process
Fig. 3 Data triangulation techniques
Fig. 4 Primary research pattern
Fig. 5 Market research approaches
Fig. 6 Value-chain-based sizing & forecasting
Fig. 7 Market formulation & validation
Fig. 8 Market snapshot
Fig. 9 Therapeutic approach and disease outlook (USD Million)
Fig. 10 Competitive landscape
Fig. 11 Hemorrhoids treatment market dynamics
Fig. 12 Hemorrhoids treatment market: Porter’s five forces analysis
Fig. 13 Hemorrhoids treatment market: PESTLE analysis
Fig. 14 Disease market, 2021 - 2033 (USD Million)
Fig. 15 Internal Hemorrhoids market, 2021 - 2033 (USD Million)
Fig. 16 External Hemorrhoids market, 2021 - 2033 (USD Million)
Fig. 17 Mixed Hemorrhoids market, 2021 - 2033 (USD Million)
Fig. 18 Drug Class market, 2021 - 2033 (USD Million)
Fig. 19 Corticosteroids market, 2021 - 2033 (USD Million)
Fig. 20 Local Anesthetics market, 2021 - 2033 (USD Million)
Fig. 21 Vasoconstrictors market, 2021 - 2033 (USD Million)
Fig. 22 Others market, 2021 - 2033 (USD Million)
Fig. 23 Distribution channel market, 2021 - 2033 (USD Million)
Fig. 24 Online pharmacy market, 2021 - 2033 (USD Million)
Fig. 25 Retail pharmacy market, 2021 - 2033 (USD Million)
Fig. 26 Hospital pharmacy market, 2021 - 2033 (USD Million)
Fig. 27 Hemorrhoids treatment market revenue, by region
Fig. 28 Regional marketplace: Key takeaways
Fig. 29 North America hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 30 U.S. country dynamics
Fig. 31 U.S. hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 32 Canada country dynamics
Fig. 33 Canada hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 34 Mexico country dynamics
Fig. 35 Mexico hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 36 Europe hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 37 UK country dynamics
Fig. 38 UK hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 39 Germany country dynamics
Fig. 40 Germany hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 41 France country dynamics
Fig. 42 France hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 43 Italy country dynamics
Fig. 44 Italy hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 45 Spain country dynamics
Fig. 46 Spain hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 47 Norway country dynamics
Fig. 48 Norway hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 49 Sweden country dynamics
Fig. 50 Sweden hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 51 Denmark country dynamics
Fig. 52 Denmark hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 53 Asia Pacific hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 54 Japan country dynamics
Fig. 55 Japan hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 56 China country dynamics
Fig. 57 China hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 58 India country dynamics
Fig. 59 India hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 60 Australia country dynamics
Fig. 61 Australia hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 62 South Korea country dynamics
Fig. 63 South Korea hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 64 Thailand country dynamics
Fig. 65 Thailand hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 66 Latin America hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 67 Brazil country dynamics
Fig. 68 Brazil hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 69 Argentina country dynamics
Fig. 70 Argentina hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 71 MEA hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 72 South Africa country dynamics
Fig. 73 South Africa hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 74 Saudi Arabia country dynamics
Fig. 75 Saudi Arabia hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 76 UAE country dynamics
Fig. 77 UAE hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 78 Kuwait country dynamics
Fig. 79 Kuwait hemorrhoids treatment market, 2021 - 2033 (USD Million)
Fig. 80 Company categorization
Fig. 81 Company market position analysis
Fig. 82 Strategic framework